Hemoperfusion and liver disease.
Biomater Artif Cells Immobilization Biotechnol
; 21(2): 265-81, 1993.
Article
em En
| MEDLINE
| ID: mdl-8318618
After first adventurous attempts to apply perfusion techniques to the treatment of liver diseases, more extensive experiences have been acquired in the last twenty years, not only in acute hepatic failure but also in some chronic liver diseases (mainly in CAH:chronic active hepatitis, and in primary biliary cirrhosis) and in a severe complication of them, that is cryoglobulinemia. Some experiences on this field that are found in literature, using both plasma exchange and hemoperfusion, are reviewed and some personal data are reported: 15 patients with acute viral liver failure (survival rate: 33%) and 5 patients with a CAH-linked (3 viral and 2 autoimmune) cryoglobulinemia, in whom a good control of the disease parameters was obtained.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Troca Plasmática
/
Hemoperfusão
/
Falência Hepática Aguda
/
Crioglobulinemia
/
Cirrose Hepática Biliar
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Biomater Artif Cells Immobilization Biotechnol
Assunto da revista:
ENGENHARIA BIOMEDICA
/
TRANSPLANTE
Ano de publicação:
1993
Tipo de documento:
Article
País de afiliação:
Itália
País de publicação:
Estados Unidos